 米国 フェンプロクーモンの市場レポート・予測 2021-2027年United States Phenprocoumon Market Report & Forecast 2021-2027 当レポートでは、米国におけるPhenprocoumonの市場規模および予測を掲載しています。 米国のPhenprocoumon市場収益、2016-2021年、2022-2027年、(百万ドル) アメリカ合衆国のPhenprocoumon市場販売数、2016-202... もっと見る
※当ページの内容はウェブ更新時の情報です。 
サマリー当レポートでは、米国におけるPhenprocoumonの市場規模および予測を掲載しています。米国のPhenprocoumon市場収益、2016-2021年、2022-2027年、(百万ドル) アメリカ合衆国のPhenprocoumon市場販売数、2016-2021年、2022-2027年、(Kユニット) 2020年におけるアメリカ合衆国のPhenprocoumonのトップ5企業(%) 世界のPhenprocoumon市場規模は、2020年のXX百万米ドルから2027年にはXX百万米ドルに成長すると予想され、2021-2027年の間にXX％のCAGRで成長すると予想されています。 米国のPhenprocoumon市場は、2020年にXX百万米ドル、2027年にXX百万米ドルに達し、予測期間中にXX％のCAGRで成長すると予測されています。 QYResearchは、Phenprocoumonのメーカー、サプライヤー、流通業者、業界専門家を対象に、売上高、収益、需要、価格変動、製品タイプ、最近の開発と計画、業界動向、ドライバー、課題、障害、潜在的リスクなど、この業界について調査しました。 総市場をセグメント別に見ると 米国のPhenprocoumon市場、タイプ別、2016-2021年、2022-2027年（単位：百万ドル）・（Kユニット) 米国のPhenprocoumon市場セグメント別割合、タイプ別、2020年(%) 5 mg 10 mg 25 mg 50 mg 米国のPhenprocoumon市場、用途別、2016-2021年、2022-2027年（単位：百万ドル）・（Kユニット） 米国のPhenprocoumon市場セグメント別割合、用途別、2020年(%) 静脈血栓症 血栓塞栓症（Thromboembolism 肺塞栓症 その他 競合他社の分析 本レポートでは、以下のような主要な市場参加者の分析も行っています。 主要企業の米国市場におけるPhenprocoumonの収益、2016-2021年（推定）、（百万ドル） 主要企業の米国市場におけるPhenprocoumonの収益シェア、2020年(%) 主要企業の米国市場におけるPhenprocoumonの販売量、2016-2021年（推定）、（Kユニット） 米国市場における主要企業のPhenprocoumonの売上高シェア、2020年(%) さらに、本レポートでは、市場における競合他社のプロファイルを紹介しています。主なプレイヤーは以下の通りです。 ノバルティス マイラン Teva ロシュ アスペン・ファルマケア Acis Arzneimittel ウエルワグ・ファーマ ディバイス・ラボ 目次1 Introduction to Research & Analysis Reports1.1 Phenprocoumon Market Definition 1.2 Market Segments 1.2.1 Segment by Type 1.2.2 Segment by Application 1.3 United States Phenprocoumon Market Overview 1.4 Methodology & Sources of Information 1.4.1 Research Methodology 1.4.2 Research Process 1.4.3 Base Year 2 United States Phenprocoumon Overall Market Size 2.1 United States Phenprocoumon Market Size: 2021 VS 2027 2.2 United States Phenprocoumon Revenue, Prospects & Forecasts: 2016-2027 2.3 United States Phenprocoumon Sales: 2016-2027 3 Company Landscape 3.1 Top Phenprocoumon Players in United States Market 3.2 Top United States Phenprocoumon Companies Ranked by Revenue 3.3 United States Phenprocoumon Revenue by Companies 3.4 United States Phenprocoumon Sales by Companies 3.5 United States Phenprocoumon Price by Manufacturer (2016-2021) 3.6 Top 3 and Top 5 Phenprocoumon Companies in United States Market, by Revenue in 2020 3.7 Manufacturers Phenprocoumon Product Type 3.8 Tier 1, Tier 2 and Tier 3 Phenprocoumon Players in United States Market 3.8.1 List of Tier 1 Phenprocoumon Companies in United States 3.8.2 List of Tier 2 and Tier 3 Phenprocoumon Companies in United States 4 Sights by Type 4.1 Overview 4.1.1 By Type - United States Phenprocoumon Market Size Markets, 2021 & 2027 4.1.2 5 mg 4.1.3 10 mg 4.1.4 25 mg 4.1.5 50 mg 4.2 By Type - United States Phenprocoumon Revenue & Forecasts 4.2.1 By Type - United States Phenprocoumon Revenue, 2016-2021 4.2.2 By Type - United States Phenprocoumon Revenue, 2022-2027 4.2.3 By Type - United States Phenprocoumon Revenue Market Share, 2016-2027 4.3 By Type - United States Phenprocoumon Sales & Forecasts 4.3.1 By Type - United States Phenprocoumon Sales, 2016-2021 4.3.2 By Type - United States Phenprocoumon Sales, 2022-2027 4.3.3 By Type - United States Phenprocoumon Sales Market Share, 2016-2027 4.4 By Type - United States Phenprocoumon Price (Manufacturers Selling Prices), 2016-2027 5 Sights by Application 5.1 Overview 5.1.1 By Application - United States Phenprocoumon Market Size, 2021 & 2027 5.1.2 Venous Thrombosis 5.1.3 Thromboembolism 5.1.4 Pulmonary Embolism 5.1.5 Others 5.2 By Application - United States Phenprocoumon Revenue & Forecasts 5.2.1 By Application - United States Phenprocoumon Revenue, 2016-2021 5.2.2 By Application - United States Phenprocoumon Revenue, 2022-2027 5.2.3 By Application - United States Phenprocoumon Revenue Market Share, 2016-2027 5.3 By Application - United States Phenprocoumon Sales & Forecasts 5.3.1 By Application - United States Phenprocoumon Sales, 2016-2021 5.3.2 By Application - United States Phenprocoumon Sales, 2022-2027 5.3.3 By Application - United States Phenprocoumon Sales Market Share, 2016-2027 5.4 By Application - United States Phenprocoumon Price (Manufacturers Selling Prices), 2016-2027 6 Manufacturers & Brands Profiles 6.1 Novartis 6.1.1 Novartis Corporation Information 6.1.2 Novartis Overview 6.1.3 Novartis Phenprocoumon Sales and Revenue in United States Market (2016-2021) 6.1.4 Novartis Phenprocoumon Product Description 6.1.5 Novartis Recent Developments 6.2 Mylan 6.2.1 Mylan Corporation Information 6.2.2 Mylan Overview 6.2.3 Mylan Phenprocoumon Sales and Revenue in United States Market (2016-2021) 6.2.4 Mylan Phenprocoumon Product Description 6.2.5 Mylan Recent Developments 6.3 Teva 6.3.1 Teva Corporation Information 6.3.2 Teva Overview 6.3.3 Teva Phenprocoumon Sales and Revenue in United States Market (2016-2021) 6.3.4 Teva Phenprocoumon Product Description 6.3.5 Teva Recent Developments 6.4 Roche 6.4.1 Roche Corporation Information 6.4.2 Roche Overview 6.4.3 Roche Phenprocoumon Sales and Revenue in United States Market (2016-2021) 6.4.4 Roche Phenprocoumon Product Description 6.4.5 Roche Recent Developments 6.5 Aspen Pharmacare 6.5.1 Aspen Pharmacare Corporation Information 6.5.2 Aspen Pharmacare Overview 6.5.3 Aspen Pharmacare Phenprocoumon Sales and Revenue in United States Market (2016-2021) 6.5.4 Aspen Pharmacare Phenprocoumon Product Description 6.5.5 Aspen Pharmacare Recent Developments 6.6 Acis Arzneimittel 6.6.1 Acis Arzneimittel Corporation Information 6.6.2 Acis Arzneimittel Overview 6.6.3 Acis Arzneimittel Phenprocoumon Sales and Revenue in United States Market (2016-2021) 6.6.4 Acis Arzneimittel Phenprocoumon Product Description 6.6.5 Acis Arzneimittel Recent Developments 6.7 Wörwag Pharma 6.7.1 Wörwag Pharma Corporation Information 6.7.2 Wörwag Pharma Overview 6.7.3 Wörwag Pharma Phenprocoumon Sales and Revenue in United States Market (2016-2021) 6.7.4 Wörwag Pharma Phenprocoumon Product Description 6.7.5 Wörwag Pharma Recent Developments 6.8 Divis Labs 6.8.1 Divis Labs Corporation Information 6.8.2 Divis Labs Overview 6.8.3 Divis Labs Phenprocoumon Sales and Revenue in United States Market (2016-2021) 6.8.4 Divis Labs Phenprocoumon Product Description 6.8.5 Divis Labs Recent Developments 7 United States Phenprocoumon Production Capacity, Analysis 7.1 United States Phenprocoumon Production Capacity, 2016-2027 7.2 Phenprocoumon Production Capacity of Key Manufacturers in United States Market 8 Key Market Trends, Opportunity, Drivers and Restraints 8.1 Market Opportunities & Trends 8.2 Market Drivers 8.3 Market Restraints 9 Phenprocoumon Supply Chain Analysis 9.1 Phenprocoumon Industry Value Chain 9.2 Phenprocoumon Upstream Market 9.3 Phenprocoumon Downstream and Clients 9.4 Marketing Channels Analysis 9.4.1 Marketing Channels 9.4.2 Phenprocoumon Distributors and Sales Agents in United States Market 10 Conclusion 11 Appendix 11.1 Note 11.2 Examples of Clients 11.3 Author Details 11.4 Disclaimer
SummaryThis report contains market size and forecasts of Phenprocoumon in United States, including the following market information: Table of Contents1 Introduction to Research & Analysis Reports1.1 Phenprocoumon Market Definition 1.2 Market Segments 1.2.1 Segment by Type 1.2.2 Segment by Application 1.3 United States Phenprocoumon Market Overview 1.4 Methodology & Sources of Information 1.4.1 Research Methodology 1.4.2 Research Process 1.4.3 Base Year 2 United States Phenprocoumon Overall Market Size 2.1 United States Phenprocoumon Market Size: 2021 VS 2027 2.2 United States Phenprocoumon Revenue, Prospects & Forecasts: 2016-2027 2.3 United States Phenprocoumon Sales: 2016-2027 3 Company Landscape 3.1 Top Phenprocoumon Players in United States Market 3.2 Top United States Phenprocoumon Companies Ranked by Revenue 3.3 United States Phenprocoumon Revenue by Companies 3.4 United States Phenprocoumon Sales by Companies 3.5 United States Phenprocoumon Price by Manufacturer (2016-2021) 3.6 Top 3 and Top 5 Phenprocoumon Companies in United States Market, by Revenue in 2020 3.7 Manufacturers Phenprocoumon Product Type 3.8 Tier 1, Tier 2 and Tier 3 Phenprocoumon Players in United States Market 3.8.1 List of Tier 1 Phenprocoumon Companies in United States 3.8.2 List of Tier 2 and Tier 3 Phenprocoumon Companies in United States 4 Sights by Type 4.1 Overview 4.1.1 By Type - United States Phenprocoumon Market Size Markets, 2021 & 2027 4.1.2 5 mg 4.1.3 10 mg 4.1.4 25 mg 4.1.5 50 mg 4.2 By Type - United States Phenprocoumon Revenue & Forecasts 4.2.1 By Type - United States Phenprocoumon Revenue, 2016-2021 4.2.2 By Type - United States Phenprocoumon Revenue, 2022-2027 4.2.3 By Type - United States Phenprocoumon Revenue Market Share, 2016-2027 4.3 By Type - United States Phenprocoumon Sales & Forecasts 4.3.1 By Type - United States Phenprocoumon Sales, 2016-2021 4.3.2 By Type - United States Phenprocoumon Sales, 2022-2027 4.3.3 By Type - United States Phenprocoumon Sales Market Share, 2016-2027 4.4 By Type - United States Phenprocoumon Price (Manufacturers Selling Prices), 2016-2027 5 Sights by Application 5.1 Overview 5.1.1 By Application - United States Phenprocoumon Market Size, 2021 & 2027 5.1.2 Venous Thrombosis 5.1.3 Thromboembolism 5.1.4 Pulmonary Embolism 5.1.5 Others 5.2 By Application - United States Phenprocoumon Revenue & Forecasts 5.2.1 By Application - United States Phenprocoumon Revenue, 2016-2021 5.2.2 By Application - United States Phenprocoumon Revenue, 2022-2027 5.2.3 By Application - United States Phenprocoumon Revenue Market Share, 2016-2027 5.3 By Application - United States Phenprocoumon Sales & Forecasts 5.3.1 By Application - United States Phenprocoumon Sales, 2016-2021 5.3.2 By Application - United States Phenprocoumon Sales, 2022-2027 5.3.3 By Application - United States Phenprocoumon Sales Market Share, 2016-2027 5.4 By Application - United States Phenprocoumon Price (Manufacturers Selling Prices), 2016-2027 6 Manufacturers & Brands Profiles 6.1 Novartis 6.1.1 Novartis Corporation Information 6.1.2 Novartis Overview 6.1.3 Novartis Phenprocoumon Sales and Revenue in United States Market (2016-2021) 6.1.4 Novartis Phenprocoumon Product Description 6.1.5 Novartis Recent Developments 6.2 Mylan 6.2.1 Mylan Corporation Information 6.2.2 Mylan Overview 6.2.3 Mylan Phenprocoumon Sales and Revenue in United States Market (2016-2021) 6.2.4 Mylan Phenprocoumon Product Description 6.2.5 Mylan Recent Developments 6.3 Teva 6.3.1 Teva Corporation Information 6.3.2 Teva Overview 6.3.3 Teva Phenprocoumon Sales and Revenue in United States Market (2016-2021) 6.3.4 Teva Phenprocoumon Product Description 6.3.5 Teva Recent Developments 6.4 Roche 6.4.1 Roche Corporation Information 6.4.2 Roche Overview 6.4.3 Roche Phenprocoumon Sales and Revenue in United States Market (2016-2021) 6.4.4 Roche Phenprocoumon Product Description 6.4.5 Roche Recent Developments 6.5 Aspen Pharmacare 6.5.1 Aspen Pharmacare Corporation Information 6.5.2 Aspen Pharmacare Overview 6.5.3 Aspen Pharmacare Phenprocoumon Sales and Revenue in United States Market (2016-2021) 6.5.4 Aspen Pharmacare Phenprocoumon Product Description 6.5.5 Aspen Pharmacare Recent Developments 6.6 Acis Arzneimittel 6.6.1 Acis Arzneimittel Corporation Information 6.6.2 Acis Arzneimittel Overview 6.6.3 Acis Arzneimittel Phenprocoumon Sales and Revenue in United States Market (2016-2021) 6.6.4 Acis Arzneimittel Phenprocoumon Product Description 6.6.5 Acis Arzneimittel Recent Developments 6.7 Wörwag Pharma 6.7.1 Wörwag Pharma Corporation Information 6.7.2 Wörwag Pharma Overview 6.7.3 Wörwag Pharma Phenprocoumon Sales and Revenue in United States Market (2016-2021) 6.7.4 Wörwag Pharma Phenprocoumon Product Description 6.7.5 Wörwag Pharma Recent Developments 6.8 Divis Labs 6.8.1 Divis Labs Corporation Information 6.8.2 Divis Labs Overview 6.8.3 Divis Labs Phenprocoumon Sales and Revenue in United States Market (2016-2021) 6.8.4 Divis Labs Phenprocoumon Product Description 6.8.5 Divis Labs Recent Developments 7 United States Phenprocoumon Production Capacity, Analysis 7.1 United States Phenprocoumon Production Capacity, 2016-2027 7.2 Phenprocoumon Production Capacity of Key Manufacturers in United States Market 8 Key Market Trends, Opportunity, Drivers and Restraints 8.1 Market Opportunities & Trends 8.2 Market Drivers 8.3 Market Restraints 9 Phenprocoumon Supply Chain Analysis 9.1 Phenprocoumon Industry Value Chain 9.2 Phenprocoumon Upstream Market 9.3 Phenprocoumon Downstream and Clients 9.4 Marketing Channels Analysis 9.4.1 Marketing Channels 9.4.2 Phenprocoumon Distributors and Sales Agents in United States Market 10 Conclusion 11 Appendix 11.1 Note 11.2 Examples of Clients 11.3 Author Details 11.4 Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
|
